Related references
Note: Only part of the references are listed.Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity
Patrick T. Ronaldson et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2020)
Monomeric α-synuclein induces blood brain barrier dysfunction through activated brain pericytes releasing inflammatory mediators in vitro
Shinya Dohgu et al.
MICROVASCULAR RESEARCH (2019)
Autonomic dysfunction in Parkinson disease and animal models
Jeanette M. Metzger et al.
CLINICAL AUTONOMIC RESEARCH (2019)
Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB
Abderahim Gaceb et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Brain pericyte activation occurs early in Huntington's disease
Thomas Padel et al.
EXPERIMENTAL NEUROLOGY (2018)
The role of brain vasculature in neurodegenerative disorders
Melanie D. Sweeney et al.
NATURE NEUROSCIENCE (2018)
PDGFRβ Cells Rapidly Relay Inflammatory Signal from the Circulatory System to Neurons via Chemokine CCL2
Lihui Duan et al.
NEURON (2018)
Brain Pericytes As Mediators of Neuroinflammation
Justin Rustenhoven et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Age-related Impairment of Vascular Structure and Functions
Xianglai Xu et al.
AGING AND DISEASE (2017)
The blood-brain barrier in systemic inflammation
Aravinthan Varatharaj et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
How can rAAV--synuclein and the fibril -synuclein models advance our understanding of Parkinson's disease?
Laura A. Volpicelli-Daley et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Pericytes of the neurovascular unit: key functions and signaling pathways
Melanie D. Sweeney et al.
NATURE NEUROSCIENCE (2016)
Platelet-derived growth factor-BB has neurorestorative effects and modulates the pericyte response in a partial 6-hydroxydopamine lesion mouse model of Parkinson's disease
Thomas Padel et al.
NEUROBIOLOGY OF DISEASE (2016)
α-Synuclein-Based Animal Models of Parkinson's Disease: Challenges and Opportunities in a New Era
Naomi P. Visanji et al.
TRENDS IN NEUROSCIENCES (2016)
Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson's Disease-like Dementia
Patrick Ejlerskov et al.
CELL (2015)
Striatal blood-brain barrier permeability in Parkinson's disease
Madison T. Gray et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients
Gesine Paul et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Increased CSF biomarkers of angiogenesis in Parkinson disease
Shorena Janelidze et al.
NEUROLOGY (2015)
String Vessel Formation is Increased in the Brain of Parkinson Disease
Panzao Yang et al.
JOURNAL OF PARKINSONS DISEASE (2015)
Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice
David A. Hartmann et al.
NEUROPHOTONICS (2015)
Brain pericytes acquire a microglial phenotype after stroke
Ilknur Ozen et al.
ACTA NEUROPATHOLOGICA (2014)
The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease?
Ethan A. Winkler et al.
BRAIN PATHOLOGY (2014)
Vascular Degeneration in Parkinson's Disease
Jian Guan et al.
BRAIN PATHOLOGY (2013)
A novel α-synuclein-GFP mouse model displays progressive motor impairment, olfactory dysfunction and accumulation of α-synuclein-GFP
Christian Hansen et al.
NEUROBIOLOGY OF DISEASE (2013)
Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model
Stephanie Janezic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pericyte loss influences Alzheimer-like neurodegeneration in mice
Abhay P. Sagare et al.
NATURE COMMUNICATIONS (2013)
Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy
Brinda Desai Bradaric et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
Increased blood-cerebrospinal fluid transfer of albumin in advanced Parkinson's disease
Valerio Pisani et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
M. Decressac et al.
NEUROBIOLOGY OF DISEASE (2012)
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Annika Armulik et al.
DEVELOPMENTAL CELL (2011)
Central nervous system pericytes in health and disease
Ethan A. Winkler et al.
NATURE NEUROSCIENCE (2011)
A Guide to Neurotoxic Animal Models of Parkinson's Disease
Kim Tieu
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2011)
Restorative Effects of Platelet Derived Growth Factor-BB in Rodent Models of Parkinson's Disease
Olof Zachrisson et al.
JOURNAL OF PARKINSONS DISEASE (2011)
MPTP Mouse Models of Parkinson's Disease: An Update
Gloria E. Meredith et al.
JOURNAL OF PARKINSONS DISEASE (2011)
Pericytes regulate the blood-brain barrier
Annika Armulik et al.
NATURE (2010)
Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor
Masabumi Shibuya
FEBS JOURNAL (2009)
Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy
Chee Yeun Chung et al.
JOURNAL OF NEUROSCIENCE (2009)
Caffeine protects against MPTP-induced blood-brain barrier dysfunction in mouse striatum
Xuesong Chen et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Mechanism of 6-hydroxydopamine neurotoxicity:: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons
J. Rodriguez-Pallares et al.
JOURNAL OF NEUROCHEMISTRY (2007)
TNF-α knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice
Chaohui Zhao et al.
NEUROBIOLOGY OF DISEASE (2007)
Expression levels of vascular endothelial growth factor and its receptors in Parkinson's disease
Keiichirou Wada et al.
NEUROREPORT (2006)
6-Hydroxydopamine-induced alterations in blood-brain barrier permeability
PM Carvey et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability
SM Stamatovic et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
M Berger et al.
BLOOD (2005)
Changes in vascularization in substantia nigra pars compacta of monkeys rendered parkinsonian
C Barcia et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Co-ordinate transcriptional regulation of dopamine synthesis genes by α-synuclein in human neuroblastoma cell lines
MJ Baptista et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Attenuation of dopamine transporter activity by α-synuclein
C Wersinger et al.
NEUROSCIENCE LETTERS (2003)
Microvascular plasticity in aging
DR Riddle et al.
AGEING RESEARCH REVIEWS (2003)
NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis
U Ozerdem et al.
DEVELOPMENTAL DYNAMICS (2001)
Lack of nigral pathology in transgenic mice expressing human α-synuclein driven by the tyrosine hydroxylase promoter
Y Matsuoka et al.
NEUROBIOLOGY OF DISEASE (2001)
MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
NW Kowall et al.
NEUROREPORT (2000)
Share Paper
